Condom usage is down for everyone in the U.S., but researchers say the trend is especially stark among teens and young adults ...

Gilead signs non-exclusive, royalty-free voluntary licensing agreements with six generic companies to market its ...

HIV expert Linda-Gail Bekker talks to The Conversation Weekly about promising results from a trial of a new drug for HIV prevention.

Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for ...

Indian pharmaceutical companies are set to produce generic versions of lenacapavir, an HIV prevention drug, under agreements ...

Goodreau believes the promotion of pre-exposure prophylaxis (PrEP), a drug that prevents HIV, is overshadowing condoms as a ...

It was less than five years ago that I had a TURP (transurethral resection of the prostate) surgery for slow urination. It is ...

Lenacapavir was approved for use in HIV-positive adults with multi-drug resistance by the European Union in August 2022 and ...

Hetero has partnered with Gilead Sciences to manufacture and distribute the HIV drug lenacapavir in 120 low- and ...